EMILY HART: Open Payments
NPI 1578153094 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 19 payments from 9 companies in 2025. Trend: 2023 $213 · 2024 $250 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $88 |
| Astellas Pharma US Inc | 5 | $86 |
| ABBVIE INC. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $19 |
| CooperSurgical, Inc. | 1 | $16 |
| Organon LLC | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: ZURZUVAE, Veozah, VRAYLAR, INJECTAFER, INTRAROSA, Paragard T 380A, NEXPLANON, SLYND.
Industry payments across IN — which companies pay providers there.
